Discontinuation report YOHIMBINE TAB 5.4MG
| Report ID | 142803 |
| Drug Identification Number | 01901885 |
| Brand name | YOHIMBINE TAB 5.4MG |
| Common or Proper name | Yohimbine Hydrochloride Tablets |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | YOHIMBINE HYDROCHLORIDE |
| Strength(s) | 5.4MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-07-20 |
| Remaining supply date | 2021-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No inventory remaining |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-07-21 | English | Compare |
| v3 | 2021-07-20 | French | Compare |
| v2 | 2021-07-20 | English | Compare |
| v1 | 2021-07-20 | English | Compare |
Showing 1 to 4 of 4